Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoximone in advanced chronic heart failure
NCT00051285Phase 3Terminated
- Sponsor
- Gilead Sciences
- Start
- Feb 2002
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of enoximone in heart failure (HF), sponsored by Gilead Sciences. Started Feb 2002; status: terminated.
02
Drugs
enoximone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00051285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00051285.